rifampicin

简明释义

英[rɪˈfæmpɪsɪn]美[raɪˈfæmpəsɪn]

n. [药] 利福平（一种半合成抗结核药）

英英释义

单词用法

同义词

反义词

例句

1.MDR-TB (Multidrug Resistant TB) describes strains of tuberculosis that are resistant to at least the two main first-line TB drugs - isoniazid and rifampicin.

耐多药结核描述至少对两种主要一线抗结核药物-异烟肼和利福平具耐药性的结核菌株。

2.The prospective pilot study enrolled 24 patients with tuberculosis who underwent FDG-PET scans prior to receiving treatment with isoniazid, rifampicin, and ethambutol.

此前瞻性的研究纳入了24例结核患者，在抗结核药物异烟肼、利福平和乙胺丁醇治疗前行FDG-PET扫描。

3.Method: To determine the dissolution of the rifampicin gastric capsules by UV spectrum method and the release of rifampicin micro pill capsules by HPLC respectively.

方法：用高效液相色谱法与紫外分光光度法分别同时测定利福平胃溶胶囊的溶出度与利福平微丸胶囊的释放度。

4.Objective: To study the curative effect and the security of the treatment with rifampicin on bacterial dysentery in children.

前言： 目的：探讨利福平对小儿急性细菌性痢疾的疗效和安全性。

5.The prospective pilot study enrolled 24 patients with tuberculosis who underwent FDG-PET scans prior to receiving treatment with isoniazid, rifampicin, and ethambutol.

此前瞻性的研究纳入了24例结核患者，在抗结核药物异烟肼、利福平和乙胺丁醇治疗前行FDG-PET扫描。

6.Each cases was conducted the patch test of Isoniazid, Rifampicin, Pyrazinamide, Ethambutol streptomycin.

对每例进行异烟肼、利福平、吡嗪酰胺、乙胺丁醇、链霉素的斑贴试验。

7.The doctor prescribed rifampicin to treat the patient's tuberculosis.

医生开了利福平来治疗患者的结核病。

8.Patients taking rifampicin should be monitored for liver function.

服用利福平的患者应该监测肝功能。

9.The use of rifampicin is essential in multidrug-resistant TB cases.

在多药耐药结核病例中，使用利福平是必不可少的。

10.Side effects of rifampicin can include nausea and fatigue.

副作用包括恶心和疲劳，服用利福平时可能会出现这些症状。

11.Healthcare professionals should educate patients about the importance of completing their rifampicin regimen.

医疗专业人员应教育患者完成他们的利福平治疗方案的重要性。

作文

Rifampicin is a powerful antibiotic that has been used for decades to treat various bacterial infections, particularly tuberculosis. This drug belongs to the class of antibiotics known as rifamycins, which are derived from the bacterium Amycolatopsis rifamycinica. The mechanism of action of rifampicin (利福平) involves inhibiting bacterial RNA synthesis by binding to the DNA-dependent RNA polymerase enzyme. This action effectively stops the growth of bacteria, making rifampicin (利福平) an essential medication in the fight against tuberculosis and other serious infections. The discovery of rifampicin (利福平) in the 1950s marked a significant breakthrough in modern medicine. Before its introduction, tuberculosis was a leading cause of death worldwide, and treatment options were limited and often ineffective. With the availability of rifampicin (利福平), healthcare providers could offer a more effective treatment regimen that significantly improved patient outcomes. The World Health Organization recognizes rifampicin (利福平) as a critical component of the standard treatment for tuberculosis, often used in combination with other drugs to prevent resistance. One of the remarkable features of rifampicin (利福平) is its ability to penetrate well into tissues and reach areas where many other antibiotics fail. This property is particularly important in treating infections that may be sequestered in the lungs or other organs. However, it is essential to use rifampicin (利福平) as prescribed, as misuse can lead to the development of drug-resistant strains of bacteria. The emergence of multidrug-resistant tuberculosis has become a global health concern, emphasizing the importance of adhering to prescribed treatment regimens that include rifampicin (利福平). Despite its effectiveness, rifampicin (利福平) is not without side effects. Patients may experience symptoms such as gastrointestinal disturbances, liver toxicity, and changes in urine color, which can turn a reddish-orange due to the drug's properties. It is crucial for patients to discuss any adverse effects with their healthcare provider to manage them appropriately. Regular monitoring of liver function is also recommended during treatment with rifampicin (利福平) to ensure safety. In addition to tuberculosis, rifampicin (利福平) is used to treat other infections, including leprosy and certain types of bacterial meningitis. Its broad-spectrum activity against various bacteria makes it a valuable tool in the arsenal of antibiotics available to clinicians. Researchers continue to study rifampicin (利福平) to explore its potential applications in treating other diseases and conditions caused by resistant bacteria. In conclusion, rifampicin (利福平) is an indispensable antibiotic that has played a crucial role in combating tuberculosis and other bacterial infections. Its unique mechanism of action and ability to penetrate tissues make it a vital component of treatment regimens. However, responsible use is imperative to prevent the development of resistance and ensure its continued effectiveness. As we move forward in the fight against infectious diseases, rifampicin (利福平) remains a cornerstone of antibiotic therapy, highlighting the importance of ongoing research and education in the medical community.